We are live on
!
Find out more
Clearstead Advisors Portfolio holdings
AUM
$10.6B
Turnover
42.91%
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+14.75%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
-$353M
(-3.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
28.93%
Holding
3,754
New
1,518
Increased
1,198
Reduced
637
Closed
93
Avg Time Held Equity + Options
2
years
Top 10 Avg Time Held Equity + Options
3
years
Top 20 Avg Time Held Equity + Options
3
years
Avg Time Held Equity only
2
years
Top 10 Avg Time Held Equity only
3
years
Top 20 Avg Time Held Equity only
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.46% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Sabre
SABR
$722M
| $130 | ﹤0.01% |
+62
| New | +$109 |
2026 Q2
0 quarters
|
|
3302
MaxLinear
MXL
$7.09B
| $129 | ﹤0.01% |
+1
| New | +$71 |
2026 Q2
0 quarters
|
|
3303
QuantumScape Corp
QS
$2.62B
| $129 | ﹤0.01% |
+17
| New | +$127 |
2026 Q2
0 quarters
|
|
3304
Electromed
ELMD
$232M
| $128 | ﹤0.01% |
+3
| New | +$96 |
2026 Q2
0 quarters
|
|
3305
Priority Technology Holdings
PRTH
$645M
| $128 | ﹤0.01% |
+19
| New | +$110 |
2026 Q2
0 quarters
|
|
3306
Delcath Systems
DCTH
$514M
| $126 | ﹤0.01% |
+10
| New | +$111 |
2026 Q2
0 quarters
|
|
3307
Phibro Animal Health
PAHC
$1.54B
| $126 | ﹤0.01% |
+4
| New | +$169 |
2026 Q2
0 quarters
|
|
3308
Wealthfront Corp
WLTH
$1.75B
| $126 | ﹤0.01% |
+14
| New | +$146 |
2026 Q2
0 quarters
|
|
3309
CVRx
CVRX
$37M
| $125 | ﹤0.01% |
+24
| New | +$155 |
2026 Q2
0 quarters
|
|
3310
Industrial Logistics Properties Trust
ILPT
$460M
| $125 | ﹤0.01% |
+14
| New | +$108 |
2026 Q2
0 quarters
|
|
3311
Franklin Covey
FC
$205M
| $124 | ﹤0.01% |
+5
| New | +$114 |
2026 Q2
0 quarters
|
|
3312
Pangaea Logistics
PANL
$515M
| $124 | ﹤0.01% |
+19
| New | +$144 |
2026 Q2
0 quarters
|
|
3313
MGP Ingredients
MGPI
$330M
| $123 | ﹤0.01% |
+7
| New | +$127 |
2026 Q2
0 quarters
|
|
3314
One Liberty Properties
OLP
$485M
| $123 | ﹤0.01% |
+5
| New | +$117 |
2026 Q2
0 quarters
|
|
3315
Leverage Shares 2X Long CRM Daily ETF
CRMG
$54.7M
| $123 | ﹤0.01% |
+30
| New | +$162 |
2026 Q2
0 quarters
|
|
3316
DELISTED
AtaiBeckley Inc
ATAI
| $122 | ﹤0.01% |
+23
| New | +$97 |
2026 Q2
0 quarters
|
|
3317
Edgewise Therapeutics
EWTX
$4.15B
| $122 | ﹤0.01% |
+3
| New | +$103 |
2026 Q2
0 quarters
|
|
3318
MeiraGTx Holdings
MGTX
$950M
| $122 | ﹤0.01% |
+9
| New | +$89 |
2026 Q2
0 quarters
|
|
|
SILA
3319
DELISTED
Sila Realty Trust
SILA
| $122 | ﹤0.01% |
+4
| New | +$117 |
2026 Q2
0 quarters
|
|
3320
GBank Financial Holdings
GBFH
$258M
| $122 | ﹤0.01% |
+4
| New | +$117 |
2026 Q2
0 quarters
|
|
3321
Ategrity Specialty Insurance
ASIC
$1.29B
| $122 | ﹤0.01% |
+5
| New | +$103 |
2026 Q2
0 quarters
|
|
3322
Arbutus Biopharma
ABUS
$850M
| $120 | ﹤0.01% |
+25
| New | +$110 |
2026 Q2
0 quarters
|
|
3323
XORTX Therapeutics
XRTX
$2.58M
| $120 | ﹤0.01% |
55
| – | – |
2022 Q3
15 quarters
|
|
3324
Evolus
EOLS
$500M
| $119 | ﹤0.01% |
17
-17
| -50% | -$100 |
2025 Q4
2 quarters
|
|
3325
El Pollo Loco
LOCO
$497M
| $119 | ﹤0.01% |
+7
| New | +$100 |
2026 Q2
0 quarters
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,518 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,518 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.